Initiation of and Adherence to Treatment for Mental Disorders: Examination of Patient Advocate Group Members in 11 Countries
Overview
Affiliations
Objective: Greater understanding of the help-seeking process is needed to reduce the level of unmet need for mental health treatment.
Design: Cross-sectional mail survey.
Study Population: The study population consisted of 3,516 respondents to a survey of members of 14 patient advocacy groups in 11 countries. Respondents reported whether they initiated and adhered to the treatment most recently recommended to them.
Outcomes: Crude and adjusted likelihoods of initiating and adhering to recommended treatment were studied.
Results: The vast majority of respondents reported initiating the most recent treatment recommended to them (94%), and most of those who initiated treatment also adhered to such treatment (83%). Predictors of initiation by the respondents included higher levels of education, having pharmacotherapy recommended to the respondent, and having received explanations about the diagnosis and treatment. Predictors of adherence to therapy included male gender, receipt of pharmacotherapy, and presence of insurance coverage. Side effects were an important reported reason for treatment dropout, with 44% of respondents reporting lifetime treatment dropout due to side effects.
Conclusions: Successful initiation and adherence to mental health treatments depend critically on patients' knowledge and awareness, clinicians' communication skills, treatment side effects, and barriers such as lack of insurance. Further study and intervention focused on these modifiable factors are needed to improve the adequacy of mental health treatment.
Collins J, Wheeler A, McMillan S, Hu J, El-Den S, Roennfeldt H Health Expect. 2024; 27(6):e70122.
PMID: 39660682 PMC: 11632627. DOI: 10.1111/hex.70122.
Owens S, Hunte H, Sterkel A, Johnson D, Johnson-Lawrence V Psychosom Med. 2017; 79(4):469-478.
PMID: 28114149 PMC: 5413390. DOI: 10.1097/PSY.0000000000000428.
Barriers to mental health care in Japan: Results from the World Mental Health Japan Survey.
Kanehara A, Umeda M, Kawakami N Psychiatry Clin Neurosci. 2014; 69(9):523-33.
PMID: 25523280 PMC: 4472610. DOI: 10.1111/pcn.12267.
[Adverse side-effect on sexual function caused by psychotropic drugs and psychotropic substances].
Cohen S, Kuhn K, Strater B, Scherbaum N, Weig W Nervenarzt. 2010; 81(9):1129-37.
PMID: 20628721 DOI: 10.1007/s00115-010-3074-9.
Pinto-Meza A, Fernandez A, Bruffaerts R, Alonso J, Kovess V, de Graaf R Soc Psychiatry Psychiatr Epidemiol. 2010; 46(4):273-80.
PMID: 20186531 DOI: 10.1007/s00127-010-0195-1.